keyword
https://read.qxmd.com/read/30804821/a-data-science-based-analysis-points-at-distinct-patterns-of-lipid-mediator-plasma-concentrations-in-patients-with-dementia
#1
JOURNAL ARTICLE
Robert Gurke, Semra Etyemez, David Prvulovic, Dominique Thomas, Stefanie C Fleck, Andreas Reif, Gerd Geisslinger, Jörn Lötsch
Based on accumulating evidence of a role of lipid signaling in many physiological and pathophysiological processes including psychiatric diseases, the present data driven analysis was designed to gather information needed to develop a prospective biomarker, using a targeted lipidomics approach covering different lipid mediators. Using unsupervised methods of data structure detection, implemented as hierarchal clustering, emergent self-organizing maps of neuronal networks, and principal component analysis, a cluster structure was found in the input data space comprising plasma concentrations of d = 35 different lipid-markers of various classes acquired in n = 94 subjects with the clinical diagnoses depression, bipolar disorder, ADHD, dementia, or in healthy controls...
2019: Frontiers in Psychiatry
https://read.qxmd.com/read/30059565/the-improvement-of-memory-deficits-after-whole-body-cryotherapy-the-first-report
#2
JOURNAL ARTICLE
J Rymaszewska, K M Urbanska, D Szczesniak, B Stanczykiewicz, E Trypka, A Zablocka
BACKGROUND: Mild Cognitive Impairments (MCI) and dementia are still incurable. The Whole-Body Cryotherapy (WBC) - short, cyclic exposure to extremely low temperatures - has proven anti-inflammatory and anti-oxidative effects. It can also induce hormonal, lipid and neural changes. OBJECTIVE: To evaluate the WBC effect on cognitive functioning and blood parameters of MCI patients. MATERIALS AND METHODS: Participants with MCI undertook 10 WBC sessions...
May 2018: Cryo Letters
https://read.qxmd.com/read/27447786/circulating-biosignatures-of-late-life-depression-lld-towards-a-comprehensive-data-driven-approach-to-understanding-lld-pathophysiology
#3
JOURNAL ARTICLE
Breno Satler Diniz, Chien-Wei Lin, Etienne Sibille, George Tseng, Francis Lotrich, Howard J Aizenstein, Charles F Reynolds, Meryl A Butters
There is scarce information about the pathophysiological processes underlying Late-Life Depression (LLD). We aimed to determine the neurobiological abnormalities related to LLD through a multi-modal biomarker approach combining a large, unbiased peripheral proteomic panel and structural brain imaging. We examined data from 44 LLD and 31 control participants. Plasma proteomic analysis was performed using a multiplex immunoassay. We evaluated the differential protein expression between groups with random intercept models...
November 2016: Journal of Psychiatric Research
https://read.qxmd.com/read/27088787/-desaturases-of-fatty-acids-fads-and-their-physiological-and-clinical-implication
#4
REVIEW
Aleš Žák, Adolf Slabý, Eva Tvrzická, Marie Jáchymová, Jaroslav Macášek, Marek Vecka, Miroslav Zeman, Barbora Staňková
States associated with insulin resistance, as overweight/obesity, type 2 diabetes mellitus (DM2), cardiovascular diseases (CVD), some cancers and neuropsychiatric diseases are characterized with a decrease of long-chain polyunsaturated fatty acids (LC-PUFA) levels. Amounts of LC-PUFA depend on the exogenous intake of their precursors [linoleic (LA) and α-linolenic acid (ALA)] and by rate of their metabolism, which is influenced by activities of enzymes, such as Δ6-desaturase (D6D, FADS2), D5D, FADS1, elongases (Elovl2, -5, 6)...
2016: Casopís Lékar̆ů C̆eských
https://read.qxmd.com/read/25092249/plasma-biosignature-and-brain-pathology-related-to-persistent-cognitive-impairment-in-late-life-depression
#5
JOURNAL ARTICLE
B S Diniz, E Sibille, Y Ding, G Tseng, H J Aizenstein, F Lotrich, J T Becker, O L Lopez, M T Lotze, W E Klunk, C F Reynolds, M A Butters
Cognitive impairment is highly prevalent among individuals with late-life depression (LLD) and tends to persist even after successful treatment. The biological mechanisms underlying cognitive impairment in LLD are complex and likely involve abnormalities in multiple pathways, or 'cascades,' reflected in specific biomarkers. Our aim was to evaluate peripheral (blood-based) evidence for biological pathways associated with cognitive impairment in older adults with LLD. To this end, we used a data-driven comprehensive proteomic analysis (multiplex immunoassay including 242 proteins), along with measures of structural brain abnormalities (gray matter atrophy and white matter hyperintensity volume via magnetic resonance imaging), and brain amyloid-β (Aβ) deposition (PiB-positron emission tomography)...
May 2015: Molecular Psychiatry
https://read.qxmd.com/read/23735822/molecular-mechanisms-of-depression-perspectives-on-new-treatment-strategies
#6
REVIEW
Undine E Lang, Stefan Borgwardt
Depression is a multicausal disorder and has been associated with the risk to develop cancer, dementia, diabetes, epilepsy and stroke. As a metabolic disorder depression has been associated with obesity, diabetes, insulin sensitivity, neuropeptide Y, glucose regulation, poor glycemic control, glucagone-like peptide-1, cholezystokinin, ghrelin, leptin, the endocannabinoid system, insulin-like growth factor and gastrin-releasing peptide. As a cardiovascular disease a close relationship exists between depression and blood pressure, heart rate, norepinephrine, sympathetic tone, vascular resistance, blood viscosity, plasma volume, intima thickness and atherosclerosis...
2013: Cellular Physiology and Biochemistry
https://read.qxmd.com/read/19748969/role-of-exercise-induced-brain-derived-neurotrophic-factor-production-in-the-regulation-of-energy-homeostasis-in-mammals
#7
REVIEW
Bente K Pedersen, Maria Pedersen, Karen S Krabbe, Helle Bruunsgaard, Vance B Matthews, Mark A Febbraio
Brain-derived neurotrophic factor (BDNF) has been shown to regulate neuronal development and plasticity and plays a role in learning and memory. Moreover, it is well established that BDNF plays a role in the hypothalamic pathway that controls body weight and energy homeostasis. Recent evidence identifies BDNF as a player not only in central metabolism, but also in regulating energy metabolism in peripheral organs. Low levels of BDNF are found in patients with neurodegenerative diseases, including Alzheimer's disease and major depression...
December 2009: Experimental Physiology
https://read.qxmd.com/read/18361538/use-of-transdermal-drug-formulations-in-the-elderly
#8
REVIEW
Laure-Zoé Kaestli, Anne-Florence Wasilewski-Rasca, Pascal Bonnabry, Nicole Vogt-Ferrier
Transdermal drug delivery systems are pharmaceutical forms designed to administer a drug through the skin to obtain a systemic effect. They ensure a constant rate of drug administration and a prolonged action. Several different types of transdermal delivery devices are available on the market. They are either matrix or reservoir systems and their main current uses are to treat neurological disorders, pain and coronary artery disease, and as hormone replacement therapy. Transdermal drug administration has a number of advantages compared with the oral route: it avoids gastrointestinal absorption and hepatic first-pass metabolism, minimizes adverse effects arising from peak plasma drug concentrations and improves patient compliance...
2008: Drugs & Aging
https://read.qxmd.com/read/18006350/low-plasma-total-cholesterol-in-patients-with-huntington-s-disease-and-first-degree-relatives
#9
JOURNAL ARTICLE
Manolis Markianos, Marios Panas, Nikolaos Kalfakis, Demetrios Vassilopoulos
Recent studies indicate altered cholesterol homeostasis in Huntington's disease (HD) after it was found that cultured human and mice cells expressing mutant huntingtin show reduced mRNA of cholesterol biosynthetic enzymes. Plasma total cholesterol (TC) levels have been connected to degenerative disorders, but data for HD are lacking. We estimated plasma TC in three groups of HD related subjects: (a) patients with overt symptomatology, (b) subjects with expanded CAG repeat number in the Huntington gene before disease onset, and (c) siblings or descendants of HD patients, with normal CAG repeat number...
March 2008: Molecular Genetics and Metabolism
https://read.qxmd.com/read/17712096/characterization-of-the-lipid-profile-in-dementia-and-depression-in-the-elderly
#10
JOURNAL ARTICLE
Nikolaos Dimopoulos, Christina Piperi, Aristea Salonicioti, Vassiliki Psarra, Charalampos Mitsonis, Ioannis Liappas, Robert W Lea, Anastasios Kalofoutis
The purpose of the study was to examine the association of plasma lipid concentrations with changes in cognitive function and depressive states in elderly Greek individuals. The study population consisted of 3 groups: A) 37 subjects with dementia, B) 33 subjects with depression, and C) 33 controls. All individuals were screened with the Mini-Mental State Examination (MMSE), the Geriatric Depression Scale (GDS), and an evaluation of their psychiatric state. Lipid profile was assessed in all subjects, and the results were statistically evaluated at P < ...
September 2007: Journal of Geriatric Psychiatry and Neurology
https://read.qxmd.com/read/16039138/increase-in-plasma-homocysteine-levels-induced-by-drug-treatments-in-neurologic-patients
#11
REVIEW
Antonio Siniscalchi, Franco Mancuso, Luca Gallelli, Guido Ferreri Ibbadu, Nicola Biagio Mercuri, Giovambattista De Sarro
Homocysteine (Hcy) is a thyol amino acid resulting from de-methylation of methionine, an essential amino acid derived from dietary proteins. It is metabolized through two pathways: re-methylation and transsulfuration, which use as cofactors folate, vitamin B6 and vitamin B12. Hyperhomocysteinemia has been identified as a risk factor for cerebrovascular disease, dementia, impaired cognitive function and depression. Several drugs may interfere with metabolic pathways of Hcy, leading to an alteration of plasma Hcy levels...
November 2005: Pharmacological Research: the Official Journal of the Italian Pharmacological Society
https://read.qxmd.com/read/15064136/immunohistochemical-localization-of-the-sigma1-receptor-in-schwann-cells-of-rat-sciatic-nerve
#12
COMPARATIVE STUDY
Gabriel Palacios, Asunción Muro, Enric Verdú, Martí Pumarola, José Miguel Vela
The sigma-1 (sigma(1)) receptors can bind different psychotropic drugs and have been implicated in schizophrenia, depression and dementia. The cloning of the sigma(1)-receptor has allowed to obtain specific antibodies and, in a recent immunohistochemical study, we demonstrated that, in addition to neurons, the sigma(1)-receptor is located in oligodendrocytes [Brain Res. 961 (2003) 92.]. In the present study using in vivo and in vitro techniques, we demonstrate the localization of the sigma(1)-receptor in Schwann cells...
May 8, 2004: Brain Research
https://read.qxmd.com/read/1574534/incomplete-reversibility-of-an-experimentally-induced-hypocholinergic-state-biochemical-and-physiological-but-not-behavioral-recovery
#13
JOURNAL ARTICLE
R W Russell, R A Booth, D J Jenden, A S Chang, K M Rice, M Roch, S D Lauretz
In previous reports, we described the experimental development of a hypocholinergic state in rats following the total replacement of dietary choline by an artificial isostere, N-aminodeanol (NADe). NADe shares most of the physicochemical and biochemical characteristics of choline (Ch) but is utilized less efficiently in pathways leading to the formation of both acetylcholine and phospholipids. This experimental model mimics many of the features of human degenrative dementias. We now discuss the behavioral and physiological effects of restoring a normal diet after the hypocholinergic state has become well established...
February 1992: Pharmacology, Biochemistry, and Behavior
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.